A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
ConclusionsPCE as IC was feasible, with promising efficacy and no effect on compliance with subsequent CRT in unresectable LA ‐SCCHN.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tomohiro Enokida,
Takenori Ogawa,
Akihiro Homma,
Kenji Okami,
Shujiro Minami,
Ayako Nakanome,
Yasushi Shimizu,
Daisuke Maki,
Yuri Ueda,
Takao Fujisawa,
Atsushi Motegi,
Akira Ohkoshi,
Jun Taguchi,
Koji Ebisumoto,
Shogo Nomura,
Susumu Okano, Tags: ORIGINAL RESEARCH Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Erbitux | Head and Neck Cancer | Hypopharyngeal Cancer | Laryngeal Cancer | Oral Cancer | Oropharyngeal Cancer | Skin | Skin Cancer | Squamous Cell Carcinoma | Toxicology